|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Section on Liver Biology, National Institutes of Health,National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
2 Laboratory of Molecular Oncology, Georgetown University Medical Center, Washington DC, Washington DC, USA
* To whom correspondence should be addressed. E-mail: bgao{at}mail.nih.gov.
Interferon-
(IFN-
) has been implicated in liver damage in animal models and chronic hepatitis C infection; however, the underlying mechanism is not clear. Here we examined the role of signal transducer and activator of transcription factor-1 (STAT1), a key-signaling molecule for IFN-
, in a model of murine hepatitis induced by injection of LPS/D-galactosamine and in human hepatoma Hep3B cells. STAT1 is rapidly activated and highly induced after injection of LPS/D-galactosamine. Both overexpression of STAT1 and hepatocellular damage are located in the same pericentral region. Disruption of the STAT1 gene abolishes LPS/D-galactosamine-induced liver injury. Studies from IFN-
-deficient mice indicate that IFN-
is the major cytokine responsible for activation and hyperexpression of STAT1 in LPS/D-galactosamine-induced hepatitis. Hep3B cells overexpressing dominant-negative STAT1 are resistant to IFN-
- and IFN-
plus tumor necrosis factor-
-induced cell death, whereas Hep3B cells overexpression of wild-type STAT1 are more susceptible to cell death. Taken together, these findings suggest that STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
This article has been cited by other articles:
![]() |
P. J. Shaw, A. C. Ditewig, J. F. Waring, M. J. Liguori, E. A. Blomme, P. E. Ganey, and R. A. Roth Coexposure of Mice to Trovafloxacin and Lipopolysaccharide, a Model of Idiosyncratic Hepatotoxicity, Results in a Unique Gene Expression Profile and Interferon Gamma-Dependent Liver Injury Toxicol. Sci., January 1, 2009; 107(1): 270 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hosui and L. Hennighausen Genomic dissection of the cytokine-controlled STAT5 signaling network in liver Physiol Genomics, July 1, 2008; 34(2): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shen, S.-S. Zheng, O. Park, H. Wang, Z. Sun, and B. Gao Activation of innate immunity (NK/IFN-{gamma}) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G1070 - G1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Numata, M. Kubo, H. Watanabe, K. Takagi, H. Mizuta, S. Okada, S. L. Kunkel, T. Ito, and A. Matsukawa Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity J. Immunol., March 15, 2007; 178(6): 3777 - 3785. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jaruga, F. Hong, W.-H. Kim, and B. Gao IFN-{gamma}/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1 Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1044 - G1052. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |